Funding Opportunities

View the Request for Applications.

Brain Canada is excited to support the Alzheimer’s Association on the Alzheimer’s Association Health Services Research in Alzheimer’s disease and Related Disorders (HSR-ADRD) Program .

The HSR-ADRD program is aimed at advancing health services research that ensures high-quality, equitable, and person-centered brain health and dementia care along the healthcare continuum, across communities and settings. 

The Alzheimer’s Association and Brain Canada Foundation are pleased to consider partnership for successful Canadian-led applications.  

This program seeks proposals that utilize rigorous methodologies to advance understanding and improvement of cognitive impairment, including mild cognitive impairment (MCI) and Alzheimer’s disease and related dementias (AD/ADRD) detection, diagnosis, and post-diagnostic care.   

This award is structured as an individual research grant, with funding administered through the recipient’s institution. Proposals should address one or more Areas of Focus. Areas of Focus represent high-priority research topics for which this program is actively seeking proposals and include:   

• The Value of Early Detection and Diagnosis: Studies should investigate outcomes associated with early detection and diagnosis on at least two levels of the dementia care ecosystem (i.e., individual/families, providers/clinicians, health systems/payers, and policy/society).  

• Care Pathways for Individuals with MCI or Dementia: Studies should consider comorbidities and investigate how people are being screened and diagnosed in different settings, and the post-diagnosis pathways for care and treatment, including pharmacological and non-pharmacological interventions or combinations thereof.  

Deadline for receipt of Letters of Intent

May 6, 2026
05:00 pm ET

Deadline for receipt of Full Applications:

July 22, 2026
05:00 pm ET

View the Request for Applications to learn more about this funding opportunity and how to apply. 

Brain Canada happy to support Cancer Research Society (CRS) for the launch of the 2026 Doctoral Research Awards. 

This program aims to support graduate students who are pursuing a doctoral degree in cancer-related research at a Canadian institution.

The Doctoral Research Award (DRA) provides funding of $35,000 per year over 2 years, totaling $70,000.  

Applications focused on research aimed at better understanding and/or addressing the underlying causes, pathophysiology, and brain-related health outcomes of brain cancer may be co-funded by Brain Canada.

Deadline for Receipt of the Registration Form:

April 29, 2026
11:59 pm ET

View the Terms of Reference to learn more about this funding opportunity and how to apply. 

Brain Canada and the ALS Society of Canada are delighted to announce the launch of the 2026 ALS Canada-Brain Canada Trainee Program. 

Brain Canada and ALS Canada believe that attracting the brightest young minds to ALS research will contribute to a succession plan for the Canadian ALS research community and will support compelling breakthroughs across the spectrum of brain-related disease.  
 
A $315,000 pool of funds will be available for this program. Each Doctoral Award would be funded at $25,000 per year for up to three years, and each Postdoctoral Fellowship would be funded at $55,000 per year for up to three years. The funds awarded through this fellowship will be utilized to support the stipend/salary of the awardee(s).  

All applicants should have demonstrated contributions to research which may or may not have related directly to ALS, but proposed future research and training must be ALS-related. 

Doctoral Scheme 

At the time of application, eligible trainees have applied to, been accepted for, or are within the first three years of a PhD program under the supervision of an investigator who holds an academic position at qualifying Canadian institution, defined according to CIHR guidelines. 

Postdoctoral Scheme 

Qualifying trainees currently hold or have secured a postdoctoral position under the supervision of an investigator who holds an academic position at a qualifying Canadian institution, defined according to CIHR guidelines. At the time of application, applicants should be transitioning from graduate work to a postdoctoral position or be within the first two years of postdoctoral studies. 

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.  

This program has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) Brain Canada Foundation, and the ALS Society of Canada. 

View the Request for ApplicationNAVIGATOR-2026-Request-for-Applications_FINALs to learn more about this funding opportunity and how to apply.

Brain Canada and the Huntington Society of Canada are pleased to announce the launch of the 2026 Navigator Research Program 

The Navigator Research Program is designed to provide funding for Canadian scientific research of direct and immediate relevance to Huntington disease; to provide a platform for the future recruitment of outstanding investigators to Huntington disease research; to facilitate research collaboration nationally and internationally, and to support research that is relevant to other neurodegenerative disorders as well as Huntington disease.  

Send Letters of Intent and applications to: research@huntingtonsociety.ca

Questions may be directed to: research@huntingtonsociety.ca

Click here to view the Guidelines

Brain Canada is excited to be one of the partners joining Health Research BC for the launch of the Advancing Groundbreaking Research in Alzheimer’s and Parkinson’s Diseases  Team Award.   
 The Advancing Groundbreaking Research in Alzheimer’s and Parkinson’s Diseases funding opportunity supports BC-based, interdisciplinary research teams working to deepen understanding of Alzheimer’s disease (AD) and Parkinson’s disease (PD), improve diagnosis, treatment, and/or care, and potentially explore shared mechanisms across neurodegenerative diseases. 

Teams must include at least two researchers (a BC-based primary applicant and a co-lead) and at least one BC-based graduate student, postdoctoral fellow, or early-career researcher.

Teams are encouraged to meaningfully engage with research users, particularly people with lived experience (PWLE; e.g., people living with Parkinson’s or Alzheimer’s and/or their caregivers/care partners), as team members, as appropriate for the project.

Letter of Intent Deadline:  February 2, 2026 at 4:30 p.m. PT
Full Application Deadline (Applicant):  March 26, 2026 at 4:30 p.m. PT
Full Application Deadline (Host Institution): April 2, 2026 at 4:30 p.m. PT

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.

This opportunity is made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the government of Canada (through Health Canada) and Brain Canada Foundation. Together in partnership with the Alzheimer Society of B.C., Branch Out Neurological Foundation, CLEAR Foundation, Health Research BC, Parkinson Society BC, and the Patrick & Dulcie Lenox Endowment, we are advancing meaningful solutions for BC’s aging population and strengthening networks between researchers, partners, and research users